These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6105602)

  • 41. Use of antipsychotic medication in the elderly.
    Maletta GJ
    Annu Rev Gerontol Geriatr; 1984; 4():175-220. PubMed ID: 6152711
    [No Abstract]   [Full Text] [Related]  

  • 42. A prospective study of tardive dyskinesia development: preliminary results.
    Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B
    J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Paradoxal neurological side-effects of neuroleptics. Classification and occurrence].
    Korsgaard S; Gerlach J; Noring U; Povlsen UJ
    Ugeskr Laeger; 1987 Jun; 149(25):1685-8. PubMed ID: 2885955
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
    Keck PE; McElroy SL; Strakowski SM; Soutullo CA
    J Clin Psychiatry; 2000; 61 Suppl 4():33-8. PubMed ID: 10739329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evolutionary origin of extrapyramidal disorders in drug-treated mental patients, its significance, and the role of neuromelanin.
    Forrest FM
    Adv Biochem Psychopharmacol; 1974; 9(0):255-68. PubMed ID: 4151764
    [No Abstract]   [Full Text] [Related]  

  • 47. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
    Bransgrove LL; Kelly MW
    Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs.
    Gualtieri TC; Barnhill J; McGinsey J; Schell D
    J Am Acad Child Psychiatry; 1980; 19(3):491-510. PubMed ID: 6106027
    [No Abstract]   [Full Text] [Related]  

  • 49. [Neuroleptics in children].
    Daléry J; Beaufrère B; Maillet J; de Villard R
    Pediatrie; 1980; 35(1):89-94. PubMed ID: 6102756
    [No Abstract]   [Full Text] [Related]  

  • 50. [First application of tablet form bromperidol in man with particular consideration of tolerance].
    Pöldinger W; Bures E
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():26-9. PubMed ID: 35474
    [No Abstract]   [Full Text] [Related]  

  • 51. Preliminary findings with regard to risk factors in the development of tardive dyskinesia [proceedings].
    Kane J; Struve F; Woerner M; Weinhold P
    Psychopharmacol Bull; 1981 Jan; 17(1):47-9. PubMed ID: 6112775
    [No Abstract]   [Full Text] [Related]  

  • 52. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ; Cazzullo CL; Cocchi A; Denber HC; Freyhan FA; Klerman GL; Köknel O; Levine J; Saarma J; Sarteschi P; Vinar O; Wittenborn JR
    Mod Probl Pharmacopsychiatry; 1970; 5():148-56. PubMed ID: 4949818
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of phenothiazines on central cholinergic activity.
    Van Woert MH; Sethy VH; Ambani LM
    Adv Biochem Psychopharmacol; 1974; 9(0):707-15. PubMed ID: 4151771
    [No Abstract]   [Full Text] [Related]  

  • 54. Haloperidol update: 1975.
    Ayd FJ
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):14-22. PubMed ID: 1019142
    [No Abstract]   [Full Text] [Related]  

  • 55. [Neuroleptics and extrapyramidal effects from the biochemical viewpoint. Discussion by the Workshop on Neuroleptics and the Extrapyramidal System].
    Seyfried C
    Arzneimittelforschung; 1978; 28(9):1537-8. PubMed ID: 38815
    [No Abstract]   [Full Text] [Related]  

  • 56. Introduction: movement disorders in psychiatry, specifically to drug-induced dyskinesias.
    Höschl C
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():1-2. PubMed ID: 11072760
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prescription of neuroleptics for children].
    Bouvard MP; Mouren-Siméoni MC
    Encephale; 1990; 16(5):389-98. PubMed ID: 1979943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroleptics and the elderly.
    Peabody CA; Warner MD; Whiteford HA; Hollister LE
    J Am Geriatr Soc; 1987 Mar; 35(3):233-8. PubMed ID: 2880887
    [No Abstract]   [Full Text] [Related]  

  • 59. Tardive dyskinesia in psychiatric patients treated with neuroleptics.
    Perris C; Dimitrijevic P; Jacobsson L; Paulsson P; Rapp W; Fröberg H
    Br J Psychiatry; 1979 Dec; 135():509-14. PubMed ID: 43756
    [No Abstract]   [Full Text] [Related]  

  • 60. Recognition and treatment of rabbit syndrome, an uncommon complication of neuroleptic therapies.
    Todd R; Lippmann S; Manshadi M; Chang A
    Am J Psychiatry; 1983 Nov; 140(11):1519-20. PubMed ID: 6137964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.